| |
| |
|
| Insider
Information: |
Hoelscher Paul W. |
| Relationship: |
EVP, CFO |
| City: |
Deerfield |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,049 |
|
|
Indirect Shares
|
139,462 |
|
|
| Direct
Value |
$29,687 |
|
|
|
Indirect Value
|
$3,946,775 |
|
|
| Total
Shares |
140,511 |
|
|
| Total
Value |
$3,976,461 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Horizon Pharma, Inc. |
HZNP |
EVP, CFO |
2022-04-20 |
1,049 |
2022-04-20 |
139,462 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2022-04-20 |
4 |
AS |
$114.36 |
$5,735,449 |
D/D |
(50,000) |
1,049 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2022-04-20 |
4 |
OE |
$22.14 |
$1,107,000 |
D/D |
50,000 |
51,049 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2022-04-06 |
4 |
AS |
$110.01 |
$10,089,026 |
I/I |
(91,710) |
66,673 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2022-04-06 |
4 |
AS |
$110.01 |
$23,688,788 |
D/D |
(215,335) |
1,049 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2022-04-06 |
4 |
OE |
$15.96 |
$4,580,417 |
D/D |
215,335 |
216,384 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2022-03-25 |
4 |
AS |
$110.00 |
$72,930 |
I/I |
(663) |
158,383 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2022-03-24 |
4 |
AS |
$110.00 |
$162,910 |
I/I |
(1,481) |
159,046 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2022-03-23 |
4 |
OE |
$15.96 |
$416,396 |
D/D |
26,090 |
27,139 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2022-03-23 |
4 |
AS |
$110.00 |
$2,870,002 |
D/D |
(26,090) |
1,049 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2022-03-23 |
4 |
AS |
$110.01 |
$1,287,018 |
I/I |
(11,699) |
160,527 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2022-03-07 |
4 |
GA |
$0.00 |
$0 |
I/I |
238,852 |
172,226 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2022-03-07 |
4 |
GD |
$0.00 |
$0 |
I/I |
172,226 |
72,789 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2022-03-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
66,626 |
1,049 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2022-01-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,558 |
70,138 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2022-01-21 |
4 |
D |
$86.42 |
$212,852 |
D/D |
(2,463) |
67,675 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2022-01-05 |
4 |
D |
$101.84 |
$5,159,825 |
D/D |
(50,666) |
64,580 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2022-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
47,375 |
115,246 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2022-01-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
66,822 |
67,871 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2021-12-28 |
4 |
OE |
$15.96 |
$136,857 |
D/D |
8,575 |
9,624 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2021-12-28 |
4 |
AS |
$110.00 |
$943,250 |
D/D |
(8,575) |
1,049 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2021-12-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,049 |
1,049 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2021-08-25 |
4 |
GA |
$0.00 |
$0 |
I/I |
6,163 |
178,389 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2021-08-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,163 |
2,098 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2021-07-28 |
4 |
D |
$102.50 |
$395,445 |
D/D |
(3,858) |
8,261 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, CFO |
• – – |
2021-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
8,708 |
12,119 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
